Approval · Notice of Compliance 1509 · 2000
VISUDYNE: Notice of Compliance 1509
Issued May 31, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1509
- Date
- May 31, 2000
- Company
- Qlt Inc.Vancouver, BC, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Photosensitizing agent for age-related macular degeneration
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VISUDYNE | 02242367 | Marketed |
Medicinal ingredients
- VERTEPORFIN 15 MG per VIAL